Showing results (51-60 of 181) with videos related to

Sort By:
Pageof 19
AIDS (London, England)|December 4, 2004
The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adultsMustafa A Noor, Rex A Parker, Edward O'Mara, et al.
Open Forum Infectious Diseases|July 17, 2015
Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for HyperbilirubinemiaSaran Vardhanabhuti, Heather J Ribaudo, Raphael J Landovitz, et al.
The Journal of Infectious Diseases|February 26, 2009
Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americansDavid W Haas, Tebeb Gebretsadik, Gail Mayo, et al.
European Journal of Clinical Pharmacology|September 26, 2009
Oral cyclosporin A inhibits CD4 T cell P-glycoprotein activity in HIV-infected adults initiating treatment with nucleoside reverse transcriptase inhibitorsTodd Hulgan, John P Donahue, Laura Smeaton, et al.
Clinical Pharmacology and Therapeutics|January 25, 2003
Effects of nelfinavir and its M8 metabolite on lymphocyte P-glycoprotein activity during antiretroviral therapyJohn P Donahue, David Dowdy, Krishna K Ratnam, et al.
Pharmacogenetics and Genomics|November 9, 2017
Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuationPaul Leger, Sanika Chirwa, Jacinta N Nwogu, et al.
The Lancet. Infectious Diseases|November 8, 2017
Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectivesLaurent Abel, Jacques Fellay, David W Haas, et al.
The Journal of Infectious Diseases|August 8, 2009
CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, HaitiPaul Leger, Rebecca Dillingham, Carole Anne Beauharnais, et al.
Journal of Neurovirology|February 21, 2014
Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384Paul D Leger, Daniel H Johnson, Gregory K Robbins, et al.
British Journal of Clinical Pharmacology|January 23, 2015
Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South AfricaPhumla Z Sinxadi, Paul D Leger, Helen M McIlleron, et al.
Pageof 19